Adding a second incretin mimetic doubles the exposure to a drug class with this warning, with no data to characterize the incremental risk magnitude
Understanding personal motivations helps tailor recommendations
The NEJM phase 2 obesity trial reports published retatrutide study design, dose groups, and safety findings
Remedy Meds weight loss guarantee If youre on the fence about prescription weight loss medication, Remedy backs up its claims of effectiveness with a money-back guarantee
Hims & Hers' weight loss business continues to be a major focus for the company, and that segment is on pace to bring in $725 million in revenue in 2025, Yemi Okupe, Hims & Hers' chief financial officer, said during the Q3 call with investors in early November
This hormone is released after eating and plays an important role in regulating blood sugar and appetite